Juniper Advisory
Juniper Advisory presents itself as a health-system transaction advisory firm focused on nonprofit and mission-driven healthcare organizations. Its stated services include hospital M&A, partnerships and affiliations, joint ventures, independence assessments, non-acute healthcare assignments, board education, and transaction execution.
What stands out about Juniper Advisory
Juniper Advisory’s public positioning centers on healthcare M&A and partnership advisory for nonprofit hospitals, health systems, and mission-driven healthcare providers. It describes a process built around situation assessment, actionable alternatives, and transaction execution, while its public experience archive includes both sell-side and buy-side assignments.[1][2][3][4][5]
What does Juniper Advisory do?
Juniper Advisory presents itself as a health-system transaction advisory firm that helps clients evaluate and complete partnership transactions. Its public positioning is focused on nonprofit hospital owners, health systems, mission-driven nonprofits, and non-acute healthcare providers.
The firm reports 250+ assignments, 35+ years of leadership, and 20+ trusted experts. It states that it is selective in the engagements it accepts, that size is not the determining factor, and that it works with organizations ranging from multi-billion-dollar national entities to small local nonprofits.[1][2][5]
Juniper Advisory publicly lists hospital M&A, independence assessments, partnerships and affiliations, joint ventures, non-acute services, and board education among its health-system partnership advisory services.
Its stated advisory work also includes strategic financial advice, market alternatives, debt-capacity analysis, valuation and available market terms, and transaction execution. The firm describes its work as addressing both financial and non-financial terms.[2][3]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Juniper Advisory?
For a nonprofit hospital, health system, or other mission-driven healthcare owner considering a sale, affiliation, merger, lease, management agreement, or joint venture, Juniper Advisory’s stated sector focus and public transaction examples provide a basis for discussing healthcare-specific alternatives. The firm’s public process also expressly addresses financial and non-financial terms and board decision-making.
An owner should confirm which legal entity would sign the engagement letter, the applicable current regulatory status, fee mechanics, reimbursable expenses, tail and termination provisions, conflicts procedures, buyer-universe process, valuation methodology, and the treatment of governance, service access, employees, and community objectives.[2][3][4][5]
What current broker-dealer, investment-adviser, or other regulatory status applies to the contracting entity and proposed transaction personnel
What are the success fee, minimum fee, reimbursable expenses, tail period, termination provisions, and any contingent compensation
What size transactions and clients does Juniper Advisory focus on?
Juniper Advisory states that it works with nonprofit hospital owners including community 501(c)(3), governmental, religious, academic, large rural, safety-net, and critical-access hospitals.
Its stated non-acute experience includes managed care plans, behavioral health, physician groups, senior living, intellectual and developmental disability services, ambulatory surgery centers, medical office buildings, and dialysis.[2]
- Crestwood Medical Center and Huntsville Hospital Health System: The experience archive identifies Juniper Advisory as buy-side advisor for the April 2, 2026 transaction.
- Riverview Health and Parkview Health: The archive identifies Riverview Health as finalizing a management services agreement with Parkview Health on November 11, 2025, with Juniper Advisory as sell-side advisor.
- MercyOne and UnityPoint Health: The archive identifies MercyOne, a member of Trinity Health, divesting Siouxland Medical Center to UnityPoint Health on September 2, 2025.
- The Bellevue Hospital and Firelands Health: The archive identifies the hospital joining Firelands Health on June 16, 2025, with Juniper Advisory as sell-side advisor.
- Marshfield Clinic Health System and Sanford Health: The archive identifies the health system joining Sanford Health on January 2, 2025, with Juniper Advisory as sell-side advisor.
The firm’s stated transaction focus includes hospital M&A, partnerships and affiliations, joint operating and management agreements, clinical affiliations, purchasing groups, information-technology consortia, back-office partnerships, and joint ventures.
Its public experience archive includes sell-side and buy-side assignments and examples involving management agreements and divestitures. The archive identifies transaction dates and advisory roles, but the archive page does not disclose transaction value, fee terms, financing terms, or detailed consideration structures.[2][5]
What does Juniper Advisory publicly disclose about fees, process and engagement terms?
The official Services page does not publish a universal fee schedule, success-fee percentage, minimum fee, expense schedule, tail period, or termination-fee schedule.
The official Contact page does not state the current operating legal entity name, current CRD number, or current broker-dealer or investment-adviser registration status.
The official experience archive identifies transactions, dates, transaction types, and advisory roles, but does not disclose transaction value, fee terms, financing terms, or detailed consideration structures on the archive page.[2][4][5]
A FINRA BrokerCheck firm report identifies JUNIPER ADVISORY L.P. as CRD #124771 and SEC #8-65720, describes it as a Delaware partnership, and states that it was formed on December 9, 2002. The report states that the entity’s brokerage-firm registration ran from May 13, 2003 to March 27, 2009 and that it is no longer registered with FINRA or a national securities exchange.
The report lists historical business activities that included M&A advisory services and assistance with private capital raising. The official Contact page does not state the current operating legal entity name, current CRD number, or current broker-dealer or investment-adviser registration status. The contracting entity and applicable current regulatory status should therefore be confirmed directly.[4][6]
Juniper Advisory states that its process includes situation assessment, actionable alternatives, and transaction execution. It says that it considers national, regional, and local markets, reviews partnership structures and organizational performance, and works with counsel during execution.
The firm also describes attention to financial and non-financial terms and board decision-making. Its stated approach identifies objectives such as access, local input, service expansion, employment, quality, and community engagement.[3]
Questions to ask before hiring Juniper Advisory
Which current legal entity would sign the engagement letter, and how does it relate to JUNIPER ADVISORY L.P.?
What current broker-dealer, investment-adviser, or other regulatory status applies to the contracting entity and proposed transaction personnel?
What are the success fee, minimum fee, reimbursable expenses, tail period, termination provisions, and any contingent compensation?
How are conflicts identified and managed, including relationships with potential strategic partners or capital providers?
Which recent transactions may be relevant based on system size, financial condition, ownership form, geography, and transaction structure?
How are valuation, market outreach, buyer selection, governance protections, service commitments, and community-benefit objectives handled?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Investment approach
- Geography / market coverage
- Company / investment criteria
- FINRA regulatory record
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.
